Why Avantor, Inc.’s (AVTR) Stock Is Up 17.31%
As of Wednesday, July 29, Avantor, Inc.’s AVTR share price has surged by 17.31%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Commentary & Analysis
Why Avantor, Inc.’s (AVTR) Stock Is Up 14.21%
As of Wednesday, July 29, Avantor, Inc.’s AVTR share price has surged by 14.21%, which has investors questioning if this is right time to sell.Omar Beirat
What You Need to Know About Avantor, Inc.'s Q3 Earnings
Avantor, Inc.'s fiscal Q3 earnings report was released on Wednesday, July 29. Let's dive in to see if (AVTR) missed or beat analyst's expectations.Tudor Pop
Is Avantor, Inc. (AVTR) Overvalued?
We dive into why Avantor, Inc. (AVTR) could be considered overvalued on 2026-07-24, based on AAII’s Value Score and Grade.Tudor Pop
Why Avantor, Inc.’s (AVTR) Stock Is Up 5.74%
As of Thursday, July 09, Avantor, Inc.’s AVTR share price has surged by 5.74%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | AVTR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,374.3 | $1,774.7 | 77% |
|
| Shares Out (Mil) | 677.2 | 94.8 | 91% |
|
| Institutional Ownership | 99.4% | 90.1% | 88% |
|
| Float (Mil) | 657.9 | 69.9 | 88% |
|
| Beta | 0.94 | 1.20 | 56% |
|
| Avg Daily Volume (000s) | 16,346 | 838 | 98% |
|
| Price Change (52-week) |
(1.1%) | 81.0% | 45% |
|
| Growth | AVTR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.5% | 7.8% | 18% |
|
| Net Income (5yr) | (45.6%) | (13.7%) | 8% |
|
| EPS (5yr) | (60.5%) | 0.7% | 2 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (2.5%) | (15.0%) | 63% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 15 | 15 | 15 | |
| Current EPS | $0.208 | $0.812 | $0.881 | |
| Month Ago EPS | $0.205 | $0.790 | $0.851 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $0.207 | $0.790 | $0.853 | |
| Year/Year Chg | 271.4% | (204.1%) | (223.6%) | |
| Financials | AVTR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6,561 | $763 | 79% |
|
| Net Income (TTM) (Mil) | ($578) | ($14) | 2% |
|
| EPS (TTM) | ($0.853) | ($0.200) | 23% |
|
| Operating Cash Flow (TTM) (Mil) | $597 | $53 | 74% |
|
| Net Cash Flow (TTM) (Mil) | ($143) | ($5) | 12% |
|
| Long-Term Debt (Q1) (Mil) | $3,661 | $270 | 82% |
|
| Enterprise Value (Q1) (Mil) | $13,117 | $2,430 | 78% |
|
| Valuation | AVTR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.67 | 3.00 | 44% |
|
| P/E | na | 43.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 5.3 | na |
|
| Ratios | AVTR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 31.8% | 47.6% | 38% |
|
| Net Margin | (8.8%) | (2.9%) | 22% |
|
| ROA | (4.7%) | (3.2%) | 30% |
|
| ROE | (9.7%) | (4.5%) | 28% |
|
| Liabilities to Assets | 51.4% | 43.0% | 43% |
|
| F-Score | 5 | 5 | 51% |
|
Passing Stock Screens
As of 7/30/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 7.0% |
| +/- S&P 500: | -0.5 |
